A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease-Reference-Cited by-同舟云学术

A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease

Published:2017-08-01 Issue:10 Volume:24 Page:2915-2924
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Jakub James W.,Murphy Brittany L.,Gonzalez Alexandra B.,Conners Amy L.,Henrichsen Tara L.,Maimone Santo,Keeney Michael G.,McLaughlin Sarah A.,Pockaj Barbara A.,Chen Beiyun,Musonza Tashinga,Harmsen William S.,Boughey Judy C.,Hieken Tina J.,Habermann Elizabeth B.,Shah Harsh N.,Degnim Amy C.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/article/10.1245/s10434-017-5927-y/fulltext.html

Reference60 articles.

1. Brinton LA, Sherman ME, Carreon JD, Anderson WF. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst. 2008;100(22):1643–-48.

2. Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170–78.

3. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23(30):7703–20.

4. Lyman GH, Somerfield MR, Giuliano AE. Sentinel lymph node biopsy for patients with early-stage breast cancer: 2016 American Society of Clinical Oncology clinical practice guideline update summary. J Oncol Pract. 2017;13(3):196–98.

5. Lyman GH, Temin S, Edge SB, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2014;32(13):1365-1383.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiological and pathological predictors of post-operative upstaging of breast ductal carcinoma in situ (DCIS) to invasive ductal carcinoma and lymph-nodes metastasis; a potential algorithm for node surgical de-escalation;Surgical Oncology;2024-10

2. Outcomes from low-risk ductal carcinoma in situ: a systematic review and meta-analysis;Breast Cancer Research and Treatment;2024-08-24

3. De-Escalating the Extent of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma in Situ Undergoing Mastectomy;Clinical Breast Cancer;2024-08

4. The Use of Sentinel Lymph Node Biopsy in Patients Undergoing Mastectomy for DCIS;Clinical Breast Cancer;2024-07

5. Is it feasible to selectively perform axillary lymph node surgery for patients with biopsy diagnosed Ductal Carcinoma in Situ? A study based on developed and validation of nomogram;2024-05-30